+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neglected Tropical Disease Treatment Market Size, Share & Trends Analysis Report by Disease (Dengue, Rabies, Trachoma, Chagas Disease), Product (Drugs, Vaccines), Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 90 Pages
  • October 2024
  • Region: Global
  • Grand View Research
  • ID: 6024633
Description Jump to:
The global neglected tropical disease treatment market size is expected to reach USD 5.25 billion by 2030, expanding at a CAGR of 4.8% during the forecast period. Increasing prevalence of neglected tropical diseases is considered to be the vital impact rendering driver.

According to the data published in the WHO in 2018, T.B. Gambiense is endemic in 24 countries of Central and West Africa. This caused around 98% of reported cases of sleeping sickness. Furthermore, according to the CDC, around 400 people are infected annually by dengue.

Moreover, according to the statistics published in the WHO in 2019, more than 1.5 billion or 24% of the world’s population are infected with soil-transmitted helminthiases. These infections are distributed widely in tropical and subtropical areas majorly occurring in America, sub-Saharan Africa, East Asia, and China.

Presence of pipeline vaccines and drugs is also considered to be one of the major factors driving the market growth over the forecast period. For instance, Bayer AG is developing Nifurtimox (BAYA2502), currently under phase III clinical trials for the treatment of Chagas disease. Furthermore, Johnson & Johnson Services Inc. is developing Bedaquiline 200mg monotherapy regimen which is under phase II clinical trials for the treatment of leprosy and the study is estimated to be completed in 2021.

In addition, Instituto Butantan and Merck & Co., Inc. collaborated to develop vaccines against dengue in 2018. The Instituto Butantan is developing a dengue vaccine candidate in Brazil, TV003, which is in an ongoing Phase III clinical trial. Merck & Co., Inc. will provide funds to Instituto Butantan for its development.

Presence of key players such as F. Hoffmann-La Roche Ltd, Bayer AG, GlaxoSmithKline plc, Novartis AG, Pfizer, Inc., Eisai Co. Ltd., Sanofi, Astellas Pharma, Takeda Pharmaceutical Company Limited, and Gilead Sciences is expected to fuel to the overall market growth. Involvement of these players in new product development is considered to be the contributing factor for the NTD treatment market.

Tropical Disease Treatment Market Report Highlights

  • Dengue held the largest segment share in 2023 owing to its increasing prevalence rate
  • Buruli ulcer is estimated to be the fastest growing segment over the forecast period owing to rising awareness about the disease
  • In 2023, drugs were anticipated to be the largest product segment
  • Vaccines are estimated to be the fastest growing segment over the forecast period due to strong presence of pipeline products
  • Asia Pacific dominated the neglected tropical disease treatment market in 2023
  • Latin America is estimated to witness the fastest growth over the forecast period

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments
  • Competitive Landscape: Explore the market presence of key players worldwide
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

The leading players in the Neglected Tropical Disease Treatment market include:

  • F. Hoffmann-La Roche Ltd
  • Bayer AG,
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer, Inc.
  • Eisai Co. Ltd.
  • Sanofi
  • Astellas Pharma
  • Takeda Pharmaceutical Company Limited
  • Gilead Sciences.


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Neglected Tropical Disease Treatment Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Neglected Tropical Disease Treatment Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Neglected Tropical Disease Treatment Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Neglected Tropical Disease Treatment Market: Product Movement Analysis, USD Million, 2023 & 2030
4.3. Drugs
4.3.1. Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Anti-Parasite
4.3.2.1. Anti-Parasite Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Antifungal
4.3.3.1. Antifungal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. Antibiotics
4.3.4.1. Antibiotics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.5. Others
4.3.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Vaccines
4.4.1. Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Neglected Tropical Disease Treatment Market: Disease Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Neglected Tropical Disease Treatment Market: Disease Movement Analysis, USD Million, 2023 & 2030
5.3. Dengue
5.3.1. Dengue Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Rabies
5.4.1. Rabies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Trachoma
5.5.1. Trachoma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Buruli Ulcer
5.6.1. Buruli Ulcer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Yaws
5.7.1. Yaws Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Leprosy
5.8.1. Leprosy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Chagas Disease
5.9.1. Chagas Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.10. Human African Trypanosomiasis
5.10.1. Human African Trypanosomiasis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.11. Leishmaniases
5.11.1. Leishmaniases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Neglected Tropical Disease Treatment Market: Regional Estimates & Trend Analysis
6.1. Neglected Tropical Disease Treatment Market Share, By Region, 2023 & 2030, USD Million.
6.2. North America
6.2.1. North America Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Canada Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Mexico Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. UK
6.3.2.1. UK Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Germany Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. France
6.3.4.1. France Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Italy Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Spain Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. China
6.4.2.1. China Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Japan
6.4.3.1. Japan Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. India
6.4.4.1. India Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.5. South Korea
6.4.5.1. South Korea Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Argentina
6.5.3.1. Argentina Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East and Africa
6.6.1. Middle East and Africa Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. UAE
6.6.2.1. UAE Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Saudi Arabia Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. South Africa
6.6.4.1. South Africa Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Kuwait Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. F. Hoffmann-La Roche Ltd
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. Bayer AG
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. GlaxoSmithKline plc
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. Novartis AG
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. Pfizer, Inc
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. Eisai Co. Ltd.,
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. Sanofi.
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.8. Astellas Pharma
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/ Strategic Initiatives
7.4.9. Takeda Pharmaceutical Company Limited
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/ Strategic Initiatives
7.4.10. Gilead Sciences
7.4.10.1. Participant’s Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Recent Developments/ Strategic Initiatives
List of Tables
TABLE 1 List of Abbreviation
TABLE 2 North America Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 3 North America Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
TABLE 4 U.S. Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 5 U.S. Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
TABLE 6 Canada Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 7 Canada Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
TABLE 8 Europe Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 9 Europe Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
TABLE 10 U.K. Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 11 U.K. Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
TABLE 12 Germany Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 13 Germany Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
TABLE 14 Asia Pacific Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 15 Asia Pacific Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
TABLE 16 Japan Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 17 Japan Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
TABLE 18 China Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 19 China Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
TABLE 20 India Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 21 India Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
TABLE 22 Indonesia Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 23 Indonesia Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
TABLE 24 Singapore Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 25 Singapore Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
TABLE 26 Philippines Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 27 Philippines Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
TABLE 28 Latin America Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 29 Latin America Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
TABLE 30 Mexico Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 31 Mexico Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
TABLE 32 Brazil Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 33 Brazil Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
TABLE 34 Argentina Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 35 Argentina Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
TABLE 36 Colombia Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 37 Colombia Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
TABLE 38 Bolivia Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 39 Bolivia Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
TABLE 40 MEA Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 41 MEA Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
TABLE 42 South Africa Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 43 South Africa Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
TABLE 44 Saudi Arabia Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 45 Saudi Arabia Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
TABLE 46 UAE Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 47 UAE Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
TABLE 48 Nigeria Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 49 Nigeria Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
TABLE 50 Ghana Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 51 Ghana Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
TABLE 52 Zimbabwe Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
TABLE 53 Zimbabwe Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
List of Figures
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Market summary
FIG. 4 Market segmentation & scope
FIG. 5 Market size and growth prospects
FIG. 6 Global Neglected Tropical Disease Treatment market- Key market driver analysis
FIG. 7 Global Neglected Tropical Disease Treatment market - Key market restraint analysis
FIG. 8 Penetration & growth prospect mapping
FIG. 9 Global Neglected Tropical Disease Treatment market - Porter’s analysis
FIG. 10 Global Neglected Tropical Disease Treatment market - PESTEL analysis
FIG. 11 Global Neglected Tropical Disease Treatment market disease outlook key takeaways
FIG. 12 Global Neglected Tropical Disease Treatment market: Disease movement analysis
FIG. 13 Dengue market estimates, 2018 - 2030 (USD Million)
FIG. 14 Rabies market estimates, 2018 - 2030 (USD Million)
FIG. 15 Trachoma market estimates, 2018 - 2030 (USD Million)
FIG. 16 Buruli ulcer market estimates, 2018 - 2030 (USD Million)
FIG. 17 Yaw's market estimates, 2018 - 2030 (USD Million)
FIG. 18 Leprosy market estimates, 2018 - 2030 (USD Million)
FIG. 19 Chagas disease market estimates, 2018 - 2030 (USD Million)
FIG. 20 Human African trypanosomiasis (sleeping sickness) market estimates, 2018 - 2030 (USD Million)
FIG. 21 Leishmaniases market estimates, 2018 - 2030 (USD Million)
FIG. 22 Soil-transmitted helminthiases market estimates, 2018 - 2030 (USD Million)
FIG. 23 Others market estimates, 2018 - 2030 (USD Million)
FIG. 24 Global Neglected Tropical Disease Treatment market Product type outlook key takeaways
FIG. 25 Global Neglected Tropical Disease Treatment market: Product type movement analysis
FIG. 26 Drugs market estimates, 2018 - 2030 (USD Million)
FIG. 27 Vaccines market estimates, 2018 - 2030 (USD Million)
FIG. 28 Regional marketplace: Key takeaways
FIG. 29 Global Neglected Tropical Disease Treatment market: Regional movement analysis
FIG. 30 North America Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
FIG. 31 U.S. Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
FIG. 32 Canada Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
FIG. 33 Europe Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
FIG. 34 U.K. Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
FIG. 35 Germany Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
FIG. 36 Asia Pacific Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
FIG. 37 Japan Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
FIG. 38 China Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
FIG. 39 India Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
FIG. 40 Indonesia Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
FIG. 41 Singapore Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
FIG. 42 Philippines Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
FIG. 43 Latin America Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
FIG 44 Brazil Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
FIG. 45 Mexico Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
FIG. 46 Argentina Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
FIG. 47 Colombia Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
FIG. 48 Bolivia Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million
FIG. 49 MEA Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
FIG. 50 South Africa Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
FIG. 51 Saudi Arabia Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
FIG. 52 UAE market, 2018 - 2030 (USD Million)
FIG. 53 Nigeria market, 2018 - 2030 (USD Million)
FIG. 54 Ghana market, 2018 - 2030 (USD Million)
FIG. 55 Zimbabwe market, 2018 - 2030 (USD Million)
FIG. 56 Strategy framework

Companies Mentioned

  • F. Hoffmann-La Roche Ltd
  • Bayer AG,
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer, Inc.
  • Eisai Co. Ltd.
  • Sanofi
  • Astellas Pharma
  • Takeda Pharmaceutical Company Limited
  • Gilead Sciences.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages90
PublishedOctober 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 3.78 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.25 Billion
Compound Annual Growth Rate4.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Neglected Tropical Disease Treatment Market by Product, Types of Diseases, Diagnostic Method - Global Forecast 2025-2030 - Product Image

Neglected Tropical Disease Treatment Market by Product, Types of Diseases, Diagnostic Method - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Neglected Tropical Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Neglected Tropical Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
Emerging Approaches to Tackle Neglected Diseases: From Molecule to End Product - Product Image

Emerging Approaches to Tackle Neglected Diseases: From Molecule to End Product

  • Book
Leishmaniasis - Pipeline Insight, 2024 - Product Image

Leishmaniasis - Pipeline Insight, 2024

  • Clinical Trials
  • 40 Pages
  • Global
From
Parasitic Diseases Therapeutics Market Report and Forecast 2023-2031 - Product Image

Parasitic Diseases Therapeutics Market Report and Forecast 2023-2031

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.